Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28044213)

  • 1. Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.
    Yeh CC; Lai CY; Chang SN; Hsieh LL; Tang R; Sung FC; Lin YK
    Int J Clin Oncol; 2017 Jun; 22(3):484-493. PubMed ID: 28044213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy.
    Fernández-Peralta AM; Daimiel L; Nejda N; Iglesias D; Medina Arana V; González-Aguilera JJ
    Int J Colorectal Dis; 2010 Feb; 25(2):141-51. PubMed ID: 19669769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between MTHFR polymorphisms and overall survival of colorectal cancer patients in Northeast China.
    Zhu L; Wang F; Hu F; Wang Y; Li D; Dong X; Cui B; Zhao Y
    Med Oncol; 2013 Mar; 30(1):467. PubMed ID: 23392576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
    Etienne-Grimaldi MC; Milano G; Maindrault-Goebel F; Chibaudel B; Formento JL; Francoual M; Lledo G; André T; Mabro M; Mineur L; Flesch M; Carola E; de Gramont A
    Br J Clin Pharmacol; 2010 Jan; 69(1):58-66. PubMed ID: 20078613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of folate metabolism-related genes and survival of patients with colorectal cancer in the Korean population.
    Jang MJ; Kim JW; Jeon YJ; Chong SY; Hong SP; Hwang SG; Oh D; Cho YK; Ji YG; Kim NK
    Gene; 2014 Jan; 533(2):558-64. PubMed ID: 24100087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele and genotype frequencies of the polymorphic methylenetetrahydrofolate reductase and colorectal cancer among Jordanian population.
    Yousef AM; Shomaf M; Berger S; Ababneh N; Bobali Y; Ali D; Al-Hasan S; Diab O; Ismail S
    Asian Pac J Cancer Prev; 2013; 14(8):4559-65. PubMed ID: 24083702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
    Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.
    Negandhi AA; Hyde A; Dicks E; Pollett W; Younghusband BH; Parfrey P; Green RC; Savas S
    PLoS One; 2013; 8(4):e61469. PubMed ID: 23626689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy.
    Stanojevic A; Spasic J; Marinkovic M; Stojanovic-Rundic S; Jankovic R; Djuric A; Zoidakis J; Fijneman RJA; Castellvi-Bel S; Cavic M
    Front Genet; 2023; 14():1299599. PubMed ID: 38288161
    [No Abstract]   [Full Text] [Related]  

  • 12. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.
    Jiang Q; Chen K; Ma X; Li Q; Yu W; Shu G; Yao K
    Cancer Detect Prev; 2005; 29(2):146-54. PubMed ID: 15829374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
    Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
    BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer.
    Afzal S; Jensen SA; Vainer B; Vogel U; Matsen JP; Sørensen JB; Andersen PK; Poulsen HE
    Ann Oncol; 2009 Oct; 20(10):1660-6. PubMed ID: 19465420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer.
    Cao HX; Gao CM; Takezaki T; Wu JZ; Ding JH; Liu YT; Li SP; Su P; Cao J; Hamajima N; Tajima K
    Asian Pac J Cancer Prev; 2008; 9(2):203-8. PubMed ID: 18712959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
    Huang ZH; Hua D; Li LH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
    Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.
    Etienne MC; Formento JL; Chazal M; Francoual M; Magné N; Formento P; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
    Pharmacogenetics; 2004 Dec; 14(12):785-92. PubMed ID: 15608557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C677T and A1298C mutations in the MTHFR gene and survival in colorectal cancer.
    Osian G; Procopciuc L; Vlad L; Iancu C; Mocan T; Mocan L
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):455-60. PubMed ID: 20076818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTHFR C677T and A1298C polymorphism's effect on risk of colorectal cancer in Lynch syndrome.
    Wiik MU; Negline M; Beisvåg V; Clapham M; Holliday E; Dueñas N; Brunet J; Pineda M; Bonifaci N; Aretz S; Klinkhammer H; Spier I; Perne C; Mayr A; Valle L; Lubinski J; Sjursen W; Scott RJ; Talseth-Palmer BA
    Sci Rep; 2023 Nov; 13(1):18783. PubMed ID: 37914736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.